Indications and Purposes
| 1 Indications And Usage Kazano Is A Dipeptidyl-Peptidase-4 (dpp-4) Inhibitor And A Biguanide Combination Product Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1.1 ) Important Limitations Of Use: Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. ( 1.1 ) 1.1 Monotherapy And Combination Therapy Kazano Is Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus When Treatment With Both Alogliptin And Metformin Is Appropriate [see Clinical Studies (14) ] . Important Limitations Of Use Kazano Is Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Alogliptin Benzoate |
|
ZINC1011 |
| 2. Metformin Hydrochloride |
|
ZINC12859773 |